BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
BioInvent International Debt to Equity Ratio : 0.0142 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0142 |
| December 31, 2025 | 0.0153 |
| September 30, 2025 | 0.0156 |
| June 30, 2025 | 0.016 |
| March 31, 2025 | 0.0197 |
| December 31, 2024 | 0.0197 |
| September 30, 2024 | 0.017 |
| June 30, 2024 | 0.0174 |
| March 31, 2024 | 0.0172 |
| December 31, 2023 | 0.0177 |
| September 30, 2023 | 0.0151 |
| June 30, 2023 | 0.0157 |
| March 31, 2023 | 0.016 |
| December 31, 2022 | 0.0168 |
| September 30, 2022 | 0.014 |
| June 30, 2022 | 0.0172 |
| March 31, 2022 | 0.0206 |
| December 31, 2021 | 0.0208 |
| September 30, 2021 | 0.0207 |
| June 30, 2021 | 0.0208 |
| March 31, 2021 | 0.0065 |
| December 31, 2020 | 0.0156 |
| September 30, 2020 | 0.0171 |
| June 30, 2020 | 0.0653 |
| March 31, 2020 | 0.1032 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0917 |
| September 30, 2019 | 0.0806 |
| June 30, 2019 | 0.0743 |
| March 31, 2019 | 0.153 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BONESUPPORT HOLDING AB | 0.0107 |
| Hansa Biopharma AB | -1.987 |
| BioArctic AB | 0.0185 |
| Swedish Orphan Biovitrum AB | 0.4162 |
| Diamyd Medical AB | 0.2051 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 56.16M |
| Total Liabilities (Quarterly) | 10.06M |
| Shareholders Equity (Quarterly) | 46.09M |
| Current Ratio | 5.316 |
| Net Debt Paydown Yield | 0.08% |